Fullmakt FarmPharma AB WED, MAR 10, 2021 00:30 CET Fullmakt More about FarmPharma: FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of [...]
Memorandum 2021 THU, MAR 4, 2021 09:30 CET Memorandum More about FarmPharma: FarmPharma AB operates in the development and distribution of veterinary products, and their first product is for prevention and treatment of bacterial and viral infections in cattle without the use of antibiotics. [...]
Press release FRI, FEB 26, 2021 04:00 CET Press release "It is very important to maintain the high tempo of the development of InterferOX and our platform in general,” - comments Irina Zaitseva, CEO of FarmPharma, -” The current pandemic situation provides the evidence [...]
FarmPharma has applied to participate in the EUREKA Eurostar program FRI, FEB 19, 2021 11:30 CET FarmPharma AB (publ) (“FarmPharma” or “Company”), in cooperation with its partners from the Karolinska institute in the framework of an international consortium, has applied for a EUREKA Eurostars grant [...]
FarmPharma signs an agreement with All-Russian Research Institute of Experimental Veterinary Medicine TUE, FEB 16, 2021 10:30 CET Today FarmPharma AB signed a collaboration agreement with Federal Scientific Centre – All-Russian Scientific Research Institute of Experimental Veterinary Medicine named after K. I. Skryabin and Y. [...]
The last day for trading including the right to dividend of shares in FarmPharma AB TUE, JAN 12, 2021 14:13 CET Today, Tuesday, January 12, is the last day that Double Bond Pharmaceutical International AB (publ) ("DBP") shares can be traded, including the right to [...]
The fourth interferon for the product InterferOX is manufactured MON, DEC 14, 2020 14:04 CET FarmPharma AB (publ) ("FarmPharma"), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the fourth recombinant cattle interferon, a component of FarmPharma's product InterferOX, is [...]
Record date set for distribution of shares in FarmPharma AB WED, NOV 25, 2020 10:04 CET The Board of Directors of Double Bond Pharmaceutical International AB (publ) ("DBP") has today decided on a record date for the distribution of shares in FarmPharma AB (publ) ("FarmPharma"). Reconciliation [...]
The third interferon for the product InterferOX is manufactured WED, AUG 12, 2020 13:55 CET FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), has today reported that the third recombinant bovine interferon that is an ingredient in FarmPharma's product InterferOX is manufactured [...]
FarmPharma receives a grant of SEK 300,000 FRI, JUN 12, 2020 10:31 CET FarmPharma AB (publ), which is a subsidiary of Double Bond Pharmaceutical International AB (publ), have been granted SEK 300,000 by Vinnova in the call "Innovative Startups step 1". The grant will support ongoing [...]